Evidence · Preprints

Conference abstracts as evidence: the weakest common citation

Evidence › Preprints risk of bias effect size needs a source

no.silvaTL225 Oct 2025#1

On the subject in the title: Conference abstracts as evidence: the weakest common citation Working notes rather than a conclusion.

Reading an unrefereed manuscript properly, and asking whether I am doing it in the right order.

What I do at the moment: check the version and the posting date, read the methods, check whether the analysis matches whatever plan is described, then read the conclusion last. The abstract I read only afterwards, on the theory that reading it first anchors everything.

Is there a step in that sequence which is doing no work, and a step I have left out?

0 likes 9mo

h.mukherjeeTL1Member26 Oct 2025#2

Quietly grateful for the plain phrasing. Not every thread gets that.

2 likes 9mo

t.lindqvistTL227 Oct 2025#3

A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties.

Happy to be the one who is wrong here if it settles the question.

8 likes 9mo

j.delacroixTL3Regular28 Oct 2025#4

t.lindqvist, post #3: A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. Happy to be the one who is wrong here if it settles the question. Go to post

Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for understanding emerging evidence, not for drawing definitive conclusions.

Adding the caveat now so it does not have to be extracted later.

20 likes in reply to #3 9mo

b.brandtTL229 Oct 2025#5

h.mukherjee, post #2: Quietly grateful for the plain phrasing. Not every thread gets that. Go to post

Building on post #3 rather than restating it.

Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the stronger citation if it exists.

0 likes in reply to #2 9mo

MSaarinenTL3Regular30 Oct 2025#6

Post #4 put the caveat in the right place and I want to underline it.

Conference abstracts are weaker than preprints and get quoted with equal confidence. An abstract is a few hundred words with no methods section.

0 likes 9mo

Suggested topics

Topic	Participants	Replies	Views	Activity
[2026 update] Conference abstracts as evidence: the weakest common citation Evidence › Preprints needs a source effect size preprint risk of bias Closed Conference abstracts as evidence: the weakest common citation — setting out what I have, and where I think it stops being reliable. Reading an unrefereed manuscript properly, and asking whether I am doing it…		2	48k	7mo
Preprint servers and what screening they do — the long version Evidence › Preprints risk of bias effect size needs a source On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion. A preprint question rather than a question about the finding in it. The…	+7	11	26k	4mo
When a preprint is the best available evidence and we say so — a second dataset Evidence › Preprints preprint risk of bias needs a source Solved When a preprint is the best available evidence and we say so — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. A preprint question rather than a…	+20	24	36k	14mo
Coming back to: Why a preprint's supplementary material is often the best part Evidence › Preprints risk of bias effect size preprint Under review Why a preprint's supplementary material is often the best part — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how this site should cite something…	+109	116	36k	2d
Citing a preprint in a maintained document: our rule and its reasoning — does this still hold? Evidence › Preprints preprint needs a source effect size Solved Under review The question in the title: Citing a preprint in a maintained document: our rule and its reasoning — does this still hold? I will give what I have already checked below so nobody repeats it. A question about…	+103	115	24k	10mo

Related topics — sharing the tags risk of bias, effect size, needs a source

Topic	Participants	Replies	Views	Activity
Levothyroxine timing: a real interaction with a simple fix Practice › Interactions needs a source metformin hypoglycaemia delayed gastric emptying Levothyroxine timing: a real interaction with a simple fix Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about levothyroxine timing, deliberately narrow,…	+20	24	60k	18mo
Second pass at: How to research a compound with no human data without deceiving yourself Compounds › Other compounds research use only custom synthesis needs a source mislabelling Second pass at: How to research a compound with no human data without deceiving yourself Writing it up because I had to work it out twice and would rather nobody else did. The question about research a…	+64	71	2.5k	13mo
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Compounds › Repair & healing peptides needs a source preprint BPC-157 Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. The question about Analytical…	+28	33	1.6k	1mo
Historical amylin analogues and what happened to them Compounds › Cagrilintide & amylin analogues randomised trial cagrilintide cagrisema effect size Posting this under the heading it deserves: Historical amylin analogues and what happened to them Everything below is what sits behind that. Proposing that historical amylin analogues deserves a maintained…	+29	36	31k	1d
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long version Compounds › Tirzepatide SURMOUNT programme randomised trial effect size tirzepatide Closed On the subject in the title: Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long version Working notes rather than a conclusion. A narrow question about Tirzepatide in type 2…	+85	90	13k	7mo

Sponsored Sigma-Aldrich — certified reference materialsReference standards, analytical reagents and certified materials for method calibration. If you are validating a method, this is where the standard comes from.Reference standards →